(Press-News.org) Despite the wide endorsement of and support for eHealth technologies, such as electronic patient records and e-prescribing, the scientific basis of its benefits—which are repeatedly made and often uncritically accepted—remains to be firmly established.
Furthermore, even for the eHealth technologies that have proven to be successful, there is little evidence to show that such tools would continue to be successful beyond the contexts in which they were originally developed. These are the key findings of a study by Aziz Sheikh (University of Edinburgh, Edinburgh, Scotland) and colleagues, and published in this week's PLoS Medicine.
In the study, the authors systematically reviewed the published systematic review literature on eHealth technologies and evaluated the impact of these technologies on the quality and safety of health care delivery. The 53 reviews (out of 108), that the authors selected according to their criteria and critically reviewed, provided the main evidence base for assessing the impact of eHealth technologies in three categories: 1) storing, managing, and transmission of data, such as electronic patient records; 2) clinical decision support, such as e-prescribing; and 3) facilitating care from a distance, such as telehealthcare devices.
The authors found that the evidence base in support of eHealth technologies was weak and inconsistent and, importantly, that there is insubstantial evidence to support the cost-effectiveness of these technologies. They also found some evidence that introducing these new technologies may sometimes generate new risks, such as prescribing practitioners becoming over-reliant on clinical decision support for e-prescribing or overestimate its functionality, resulting in decreased practitioner performance.
The authors conclude, "in the light of the paucity of evidence in relation to improvements in patient outcomes, as well as the lack of evidence on their cost-effectiveness, it is vital that future eHealth technologies are evaluated against a comprehensive set of measures, ideally throughout all stages of the technology's life cycle." They add: "Such evaluation should be characterised by careful attention to socio-technical factors to maximise the likelihood of successful implementation and adoption."
INFORMATION:
Funding: This work was funded by the NHS Connecting for Health Evaluation Programme (NHS CFHEP 001), http://www.haps.bham.ac.uk/publichealth/cfhep/. ADP is supported by an ESRC PhD studentship in eHealth. BM is supported by a CSO Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: BM has received research grants from Intel, Tunstall, Chief Scientist Office, and NHS Lothian to explore the use of Telehealthcare in longterm conditions. AS is on the PLoS Medicine Editorial Board.
Citation: Black AD, Car J, Pagliari C, Anandan C, Cresswell K, et al. (2011) The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview. PLoS Med 8(1): e1000387. doi:10.1371/journal.pmed.1000387
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000387
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-08-01-sheikh.pdf
CONTACT:
Aziz Sheikh
Edinburgh University
Centre for Population Health Sciences
General Practice Section
Teviot Place
Edinburgh, EH8 9AG
United Kingdom
+44 131 651 4151
aziz.sheikh@ed.ac.uk
Little evidence to support most eHealth technologies, such as electronic patient records
2011-01-19
ELSE PRESS RELEASES FROM THIS DATE:
Statins: Benefits questionable in low-risk patients
2011-01-19
There is not enough evidence to recommend the widespread use of statins in people with no previous history of heart disease, according to a new Cochrane Systematic Review. Researchers say statins should be prescribed with caution in those at low risk of cardiovascular disease (CVD).
CVD is the most common cause of death, accounting for nearly a third of all deaths worldwide. Cholesterol-lowering statins are first line treatments for heart patients and the benefits are well established. However, there is less evidence that statins are beneficial for preventing heart problems ...
Drug used to treat heavy periods will stop trauma patients bleeding to death
2011-01-19
Tranexamic acid (TXA), a drug used to treat heavy menstrual periods, could save the lives of tens of thousands of bleeding accident victims each year and reduce combat deaths, say Cochrane researchers. The researchers carried out a systematic review of trials examining the effectiveness of tranexamic acid (TXA) in patients with bleeding after severe injury.
TXA is an inexpensive drug that reduces clot breakdown. It has been used for many years to reduce heavy menstrual bleeding and is often given during planned surgery to reduce the need for blood transfusion. However, ...
Antioxidants may improve chances of conceiving in male subfertility
2011-01-19
Antioxidant supplements may benefit couples who have difficulty conceiving naturally, according to a new systematic review published today in The Cochrane Library. The review provides evidence from a small number of trials that suggest the partners of men who take antioxidants are more likely to become pregnant.
Male subfertility affects one in 20 men. Chemicals called reactive oxygen species (ROS) are said to cause damage to cells, and in particular sperm cells, which may result in lowered sperm counts and interfere with their ability to fertilise eggs. Antioxidants ...
Making health information technology more patient-centered
2011-01-19
RICHMOND, Va. (Jan. 19, 2011) – Personal health records have great potential to help patients manage their health, but technology needs to be designed with the patient in mind – which means doing more than helping patients access health information, according to an editorial by two Virginia Commonwealth University family medicine physicians published in the Jan.19 issue of the Journal of the American Medical Association.
In the editorial, Alexander Krist, M.D., M.P.H., associate professor in the Department of Family Medicine in the VCU School of Medicine, together with ...
Eating more fruit and vegetables is linked to a lower risk of dying from ischemic heart disease
2011-01-19
A European study investigating the links between diet and disease has found that people who consume more fruit and vegetables have a lower risk of dying from ischaemic heart disease – the most common form of heart disease and one of the leading causes of death in Europe. However, the authors point out that a higher fruit and vegetable intake occurs among people with other healthy eating habits and lifestyles, and that these factors could also be associated with the lower risk of dying from IHD. The study is published online today (Wednesday 19 January) in the European Heart ...
Korean researchers reveal new sea defense model
2011-01-19
Los Angeles, CA (January 18, 2010) - Military tension between North Korea and the Republic of Korea (South Korea) extends to areas of the Yellow Sea. Now defence experts based in the Republic of Korea have devised improved methods to model underwater warfare, which they believe can aid future decisions about weapons and defence purchases. The details appear today in the Journal of Defense Modeling and Simulation, published by SAGE.
The researchers based at the Korea Advanced Institute of Science and Technology (KAIST) and Seowon University, both in the Republic of Korea, ...
A different path to fat-related heart disease
2011-01-19
VIDEO:
A team led by Rolf Bodmer, Ph.D., at Sanford-Burnham Medical Research Institute recently unraveled an alternative pathway to lipotoxic cardiomyopathy in fruit flies -- a genetic mechanism that occurs independently...
Click here for more information.
LA JOLLA, Calif., January 18, 2011 – Heart disease is the leading cause of death for both men and women in the United States. But heart disease is more than just one disease; there are many different 'flavors' that can result ...
Weizmann Institute scientists discover: Antioxidants cause fertility problems in females
2011-01-19
Antioxidants are sold over the counter everywhere. They're added to food, drink and face cream. But according to Prof. Nava Dekel of the Biological Regulation Department, we still don't have a complete understanding of how they act in our bodies. New research by Dekel and her team, recently published in the Proceedings of the National Academy of Sciences USA (PNAS), has revealed a possible unexpected side effect of antioxidants: They might cause fertility problems in females.
Common antioxidants include vitamins C and E. These work by eliminating molecules called reactive ...
Scientists identify avoidable breast cancer risk factors
2011-01-19
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
However, neither an individual woman nor medicine can influence whether family members develop breast cancer or at what age menopause starts - these are risk factors on which we have no influence. Scientists of the German Cancer Research Center in the team of Associate Professor (PD) Dr. Karen Steindorf and Professor Dr. ...
2 new species of 'leaping' beetles discovered in New Caledonia
2011-01-19
Only five species of these so-called 'flea' beetles, out of a global total of 60, had been found to date in New Caledonia, in the western Pacific. A three-year study has now enabled Spanish researchers to discover two new herbivorous beetles – Arsipoda geographica and Arsipoda rostrata. These new beetles hold a secret – they feed on plants that the scientists have still not found on the archipelago.
"The study, financed by the National Geographic, went some way beyond merely classifying species, and investigated the ecology of these herbivorous insects with a prodigious ...